TP53 and neuroendocrine neoplasm: A positive correlation between PGC-1α and ASCL1 was also observed in high-grade serous ovarian carcinomas (HGSOC), which share genomic alterations with neuroendocrine tumors including mutations in TP53, loss of RB1, and amplification of MYC (45).